AMN Healthcare Services, Inc. (NYSE:AHS) has reported an 120.63 percent jump in profit for the quarter ended Jun. 30, 2015. The company has earned $15.87 million, or $0.32 a share in the quarter, compared with $7.19 million, or $0.15 a share for the same period last year. AMN Healthcare Services Inc. (NYSE:AHS) belongs to Healthcare sector. Its net profit margin is 3.40% and weekly performance is 19.52%. On last trading day company shares ended up $34.17. AMN Healthcare Services Inc. (NYSE:AHS) distance from 50-day simple moving average (SMA50) is 15.78%.
Arrowhead Research Corp. (NASDAQ:ARWR) on Tuesday reported a loss of $15.9 million in its fiscal third quarter. On a per-share basis, the Pasadena, California-based company said it had a loss of 27 cents. The drug developer posted revenue of $124,000 in the period. Arrowhead Research Corp. (NASDAQ:ARWR) shares increased 12.27% in last trading session and ended the day at $6.77. ARWR return on assets is -48.50%. Arrowhead Research Corp. (NASDAQ:ARWR) quarterly performance is -1.46%.
Inotek Pharmaceuticals Corp (NASDAQ:ITEK) had its price objective lifted by Piper Jaffray from $9.00 to $29.00in a resaerch note published onTuesday morning, Marketbeat reports. Piper Jaffray currently has an overweight rating on the stock. On 05 August, Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) shares increased 14.67% and was closed at $14.62. Inotek Pharmaceuticals Corporation (NASDAQ:ITEK) year to date (YTD) performance is 143.67%.
Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM) announced that it has issued a letter to shareholders providing an update on the progress it has made to advance its two drug candidates, Iomab-B and Actimab-A, towards commercialization. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) ended the last trading day at $1.81. Company weekly volatility is calculated as 17.56% and price to cash ratio as 3.61. Actinium Pharmaceuticals, Inc. (NYSEMKT:ATNM) showed a weekly performance of -20.26%.
AmSurg Corp. (NASDAQ:AMSG) reported a strong second-quarter 2015 with adjusted earnings per share (EPS) of 92 cents from continuing operations, reflecting a solid 48.4% rise from the year-ago quarter. Adjusted earnings also exceeded the Zacks Consensus Estimate by 15% and the company’s guidance of 81−84 cents. Solid revenue growth in the quarter was primarily responsible for the year-over-year earnings improvement.AmSurg Corp. (NASDAQ:AMSG) shares increased 12.28% in last trading session and ended the day at $82.27. AMSG Gross Margin is 91.30% and its return on assets is 1.50%. AmSurg Corp. (NASDAQ:AMSG) quarterly performance is 29.44%.